The previous page is sending you to http://www.marketwatch.com/story/genzyme-submits-applications-to-fda-and-ema-for-approval-of-lemtradatm-alemtuzumab-for-multiple-sclerosis-2012-06-12.

 If you do not want to visit that page, you can return to the previous page.